Reporting owner · CIK 0001161662

Riedel Norbert G

Visual SEC Form 4 history across 2 companies, 13 transactions and 5 filings.

DIRJazz Pharmaceuticals plc
Open-market mix
Latest filingSep 02, 2026, 09:31 PM
Filings5Form 4 records
Buying$00 purchases
Selling$00 sales
Net value$0Buys minus sells
Companies24 securities
Most recentAug 31, 2026withholding

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
No open-market purchases or sales in this history.

Net value flow

Buys minus sells

Jan 25
$0
Jan 26
$0
Feb 26
$0
Aug 26
$0

Transaction texture

Ownership and ticket size

Average P/S size—
Median P/S size—
Direct13
Indirect0
Aug 31, 2026withholding

Filing-only signals

Deterministic matches in this insider's history

Derivative Transactionfiling-context7Direct Ownershipfiling-context11Large Holdings Increaseholdings4

Latest Form 4 facts

Quick context from source filings

Latest transaction

No latest transaction fact is available.

Latest buy

No open-market insider purchase is available.

Latest sale

No open-market insider sale is available.

Associated companies

Visual map of known reporting history

JAZZJazz Pharmaceuticals plc2 transactions · latest Sep 02, 2026, 09:31 PMETONEton Pharmaceuticals, Inc.11 transactions · latest Feb 05, 2026, 10:18 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
ETONRIEDEL NORBERT G
DIR
exercise50.0k$18.9MM
Direct Ownership Large Holdings Increase
—01/06/202501/03/2025
ETONRIEDEL NORBERT G
DIR
exercise27.4k$9.80MM
Direct Ownership Large Holdings Increase
—01/06/202501/03/2025
ETONRIEDEL NORBERT G
DIR
grant25.0k$0A
Derivative Transaction Direct Ownership Large Holdings Increase
—01/06/202501/03/2025

Riedel Norbert G Insider Activity FAQ

SEC Form 4 context

Who is Riedel Norbert G?

Riedel Norbert G is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001161662.

Which companies has Riedel Norbert G reported transactions for?

Jazz Pharmaceuticals plc, Eton Pharmaceuticals, Inc.

When was Riedel Norbert G's latest insider buy?

No open-market insider purchase is available for this period.

When was Riedel Norbert G's latest insider sale?

No open-market insider sale is available for this period.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.